Feds Investigating Prescription Drug Price Increases
Nelson has been critical of the $80 billion agreement. In fact, he called for a larger share of savings from the pharmaceutical manufacturers during a Senate Finance Committee hearing in September.
In an amendment, he proposed that the pharmaceutical industry "surrender a financial windfall" it gets on drugs sold to Medicare patients who also qualify for Medicaid, called "dual eligibles." The amendment, which Nelson said would saved taxpayers an estimated $106 billion over 10 years, was based on estimates provided by the Congressional Budget Office. It was defeated in a 13-10 vote at that time.
Janice Simmons is a senior editor and Washington, DC, correspondent for HealthLeaders Media Online. She can be reached at email@example.com.
- 'Kafkaesque' Value System Unfairly Penalizes Doctor Pay
- Proton Beam Therapy Poised for Growth in US
- mHealth Tackles Readmissions
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Some Cancer Hospitals' Quality Data Will Soon Be Public
- 4 Crucial Tactics for Reining in Healthcare Cost
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- How, and Why, to Recruit Male Nurses
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- Docs Fret as HHS Addresses Malpractice Reporting 'Loopholes'